Ki20227: A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model
Peptide Solubility
The former are water-soluble and act on the surface of target cells via second messengers.
